Trademark: EXTELLIA THERAPEUTICS 1798125
Word
EXTELLIA THERAPEUTICS
ID
1798125
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
29 June 2016
Registration Date
29 June 2016
Cancellation Date
06 April 2020
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy
Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy
Class 42:
Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services
Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services